UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

The lancet oncology, 2019-01, Vol.20 (1), p.43-56

2019

Link zum Volltext

Verfügbarkeit prüfen

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug

The Journal of clinical investigation, 2008-07, Vol.118 (7), p.2427-2437

2008

Link zum Volltext

Verfügbarkeit prüfen

Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity

PloS one, 2013-10, Vol.8 (10), p.e76781-e76781

2013

Link zum Volltext

Verfügbarkeit prüfen

Obinutuzumab for the treatment of indolent lymphoma

Future oncology (London, England), 2016-08, Vol.12 (15), p.1769-1781

2016

Link zum Volltext

Verfügbarkeit prüfen

The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia

Nature communications, 2017-11, Vol.8 (1), p.1679-12, Article 1679

2017

Link zum Volltext

Verfügbarkeit prüfen

Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC

PloS one, 2012-12, Vol.7 (12), p.e51390-e51390

2012

Link zum Volltext

Verfügbarkeit prüfen

Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes

Signal transduction and targeted therapy, 2023-02, Vol.8 (1), p.80-80, Article 80

2023

Link zum Volltext

Verfügbarkeit prüfen

Chronic Lymphocytic Leukemia: An Update on Biology and Treatment

Current oncology reports, 2011-10, Vol.13 (5), p.379, Article 379

2011

Link zum Volltext

Verfügbarkeit prüfen

Single cell analysis of clonal architecture in acute myeloid leukaemia

Leukemia, 2019-05, Vol.33 (5), p.1113-1123

2019

Link zum Volltext

Verfügbarkeit prüfen

Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia

Leukemia research, 2009-03, Vol.33 (3), p.368-376

2009

Link zum Volltext

Verfügbarkeit prüfen

Chronic lymphocytic leukaemia

Nature reviews. Disease primers, 2017-01, Vol.3 (1), p.16096-16096, Article 16096

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome

Leukemia, 2013-02, Vol.27 (2), p.362-369

2013

Link zum Volltext

Verfügbarkeit prüfen

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

Annals of oncology, 2013-03, Vol.24 (3), p.561-576

2013

Link zum Volltext

Verfügbarkeit prüfen

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

Oncogene, 2023-12, Vol.42 (50), p.3670-3683

2023

Link zum Volltext

Verfügbarkeit prüfen

Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia

The Journal of clinical investigation, 2020-06, Vol.130 (6), p.3038-3050

2020

Link zum Volltext

Verfügbarkeit prüfen

CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia

Science translational medicine, 2022-06, Vol.14 (650), p.eabn3248

2022

Link zum Volltext

Verfügbarkeit prüfen

The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2023-06, Vol.58 (6), p.621-624

2023

Link zum Volltext

Verfügbarkeit prüfen

Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells

Leukemia, 2018-08, Vol.32 (8), p.1818-1822

2018

Link zum Volltext

Verfügbarkeit prüfen

Indolent B-Cell Malignancies: Immune Recognition and Antiself

Leukemia & lymphoma, 2003-11, Vol.44 (S3), p.S77-S83

Gribben, John G

2003

Link zum Volltext

Verfügbarkeit prüfen

Frequency of leukemic initiating cells does not depend on the xenotransplantation model used

Leukemia, 2012-04, Vol.26 (4), p.858-860

2012

Link zum Volltext

Verfügbarkeit prüfen

Targeting the microenvironment

Leukemia & lymphoma, 2010-08, Vol.51 (S1), p.34-40

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Immunological Assessment of High Dose Combination Therapy and Autologous Bone Marrow Transplantation in the Haematological Malignancies

Gribben, John G

1990

Link zum Volltext
ProQuest

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

KollektionPublisher website

KollektionWiley Online Library

ThemaLeukemia

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(24)
Dissertationen
(1)

Sprache

Englisch
(25)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(23)
Science & Technology
(21)
Life Sciences & Biomedicine
(16)
Oncology
(14)
Hematology
(10)
Animals
(8)
Mice
(8)
Cancer
(7)
Chemotherapy
(7)
Stem Cell Transplantation
(7)
Kinases
(6)
Stem Cells
(6)
Acute Myeloid Leukemia
(5)
Bone Marrow
(5)
Chronic Lymphatic Leukemia
(5)
Chronic Lymphocytic Leukemia
(5)
Immunoglobulins
(5)
Immunotherapy
(5)
Leukemia, Lymphocytic, Chronic, B-Cell - Immunology
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma

High Throughput Sequencing Analysis of the Immunoglobulin Heavy Chain Gene from Flow-Sorted B Cell Sub-Populations Define the Dynamics of Follicular Lymphoma Clonal Evolution

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug

Antigen presenting cell-mediated expansion of human umbilical cord blood yields log-scale expansion of natural killer cells with anti-myeloma activity

Obinutuzumab for the treatment of indolent lymphoma

The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia

Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia

Generation of functional CLL-specific cord blood CTL using CD40-ligated CLL APC

Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes

Chronic Lymphocytic Leukemia: An Update on Biology and Treatment

Single cell analysis of clonal architecture in acute myeloid leukaemia

Computational identification of CDR3 sequence archetypes among immunoglobulin sequences in chronic lymphocytic leukemia

Chronic lymphocytic leukaemia

Long-term follow-up of reduced-intensity allogeneic stem cell transplantation for chronic lymphocytic leukemia: prognostic model to predict outcome

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML

Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia

CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia

The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT

Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells

Indolent B-Cell Malignancies: Immune Recognition and Antiself

Frequency of leukemic initiating cells does not depend on the xenotransplantation model used

Targeting the microenvironment

Clinical and Immunological Assessment of High Dose Combination Therapy and Autologous Bone Marrow Transplantation in the Haematological Malignancies

Aktive Filter

Suchergebnisse filtern